Queen's University

Running trials

• Not yet recruiting

  Dialysis Less Frequently in the Elderly

  NCT07738731· Source

• Recruiting

  TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS

  NCT07893964· Phase 2· Source

• Recruiting

  Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

  NCT06746155· Source

• Recruiting

  Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

  NCT06081348· Phase 2· Source

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Source

• Recruiting

  An Innovative Master Platform for Clinical Trials in Mood Disorders

  NCT06408012· Source

• Recruiting

  Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

  NCT05017311· Phase 4· Source

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· Source

• Active, not recruiting

  ERG Components in Schizophrenia and Bipolar Disorder Type I

  NCT03788811· Source

• Active, not recruiting

  A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

  NCT03127631· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Autism2 recruiting
• Chronic kidney disease2 recruiting
• Depression2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Source

• Completed

  Genetics of the Early and Late Response to Allergen Challenge

  NCT01113697· Source